Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
3 hedge funds and large institutions have $129K invested in Bionano Genomics, Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$12.5K |
Top Sellers
BNGOW Hedge Fund Activity: Q4 2021 in Review
3 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q4 2021, worth a combined $129K.
Buyers outnumbered sellers: 2 funds opened new BNGOW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $12.5K.
- 3 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q4 2021, up from 1 in Q3 2021.
- Funds reported $129K of Bionano Genomics, Inc. Warrant stock for Q4 2021.
- 2 funds opened new Bionano Genomics, Inc. Warrant positions in Q4 2021 and 0 closed out, a net change of +2 holders.
- The largest Bionano Genomics, Inc. Warrant buyer in Q4 2021 was UBS Group, an estimated $12.5K added.
Based on aggregated 13F filings for Q4 2021.